Chronic lower respiratory diseases, including chronic obstructive pulmonary disease (COPD), are the sixth leading cause of ...

In India, the prevalence of chronic kidney disease (CKD) has reached epidemic proportions, with population-based studies ...

In 2024, the Hatch-Waxman Act continued to play a critical role in the U.S. pharmaceutical landscape, driving the dynamics between ...

Explore strategies for controlling COPD and improving health, with a focus on management and lifestyle changes.

Researchers have identified new lung function and blood test cutoffs to improve timely chronic hypercapnia management in ...

Chronic lower respiratory diseases, including chronic obstructive pulmonary disease (COPD), are the sixth leading cause of death in the United States, according to the U.S. Centers for Disease Control ...

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

Among patients with COPD who experienced an exacerbation, the risk for cardiovascular events was highest in the following 2 weeks and stayed elevated more than 1 year after, according to study results ...

Study reveals the Prospector calculator reduces antibiotic prescriptions in COPD exacerbations, improving outcomes and ...

Injurious falls are common among people with chronic obstructive pulmonary disease (COPD) in the two years before de ...